NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 17, 2026 — Lixte Biotechnology advances first-in-class PP2A inhibitor LB-100 in combination cancer therapy trials. Learn how precision oncology is shifting toward multi-drug regimens for better patient outcomes.
April 17, 2026 — HeartBeam raises $10M to commercialize FDA-cleared 3D ECG technology for portable cardiac monitoring. Learn how this innovation could transform heart attack detection.
April 17, 2026 — Soligenix reports positive phase 3 data for HyBryte therapy in CTCL treatment, showing promising results compared to existing options. Read the latest clinical updates.
April 17, 2026 — LIXTE Biotechnology's LB-100 enhances cancer therapy effectiveness through PP2A inhibition. Clinical trials target ovarian, colon cancers & sarcoma with novel activation lethality approach.
April 17, 2026 — Cardio Diagnostics uses AI, genetics & epigenetics to revolutionize cardiovascular disease prevention & management. Learn how their precision medicine approach transforms heart health.
April 17, 2026 — Soligenix receives EU orphan drug designation for SGX945 in Behçet's disease treatment, validating its dusquetide-based therapy and strengthening its rare disease pipeline.
April 17, 2026 — Lixte Biotechnology's LB-100 enhances cancer treatment combos in precision oncology shift. First-in-class PP2A inhibitor boosts chemo & immunotherapy effectiveness in clinical trials.
April 17, 2026 — Gallup survey shows Americans using AI to supplement healthcare visits, with variations by age and income. Stakeholders like Astiva Health must adapt to this tech-driven shift in patient behavior.
April 17, 2026 — New study finds AI diagnostic errors exceed 80% in medical settings, highlighting safety concerns. Research shows generative AI lacks reasoning for clinical use despite improved performance with detailed patient data.
April 17, 2026 — American Academy of Neurology & American Heart Association award 2026 Sacco Scholarships to neuroscientists studying childhood concussions and exercise's impact on brain health.
April 17, 2026 — HeartBeam raises $10M to commercialize FDA-cleared portable 12-lead ECG technology that enables remote cardiac monitoring and heart attack detection outside medical facilities.
April 16, 2026 — Soligenix reports positive Phase 3 data for HyBryte CTCL therapy, showing consistent response rates and favorable results compared to existing treatment Valchlor.
April 16, 2026 — A new AI tool could boost early lung cancer detection, improving survival rates. Learn about Calidi Biotherapeutics and BioMedWire's role in sharing this breakthrough news in biotechnology.
April 16, 2026 — Oncotelic Therapeutics reports $249M net income for FY 2025, driven by GMP Bio JV valuation gain. The biopharma firm is developing OT-101 for cancer & COVID-19, plus 5 nanoparticle compounds.
April 16, 2026 — NextPlat's PharmcoRx subsidiary deploys AI-powered prescription processing technology to automate pharmacy workflows, improve efficiency, and support scalable growth in healthcare management.
April 16, 2026 — Helus Pharma appoints Dr. Ken Kramer as SVP of medical affairs to advance novel mental health treatments. Company developing NSAs for depression and anxiety with FDA breakthrough designation.
April 16, 2026 — Stacey Eisenberg launches Peter's Memory Beads, a tactile brain health tool inspired by a 116-year-old's habit. Proceeds support Alzheimer's Association research.
April 16, 2026 — Catalyst Crew Technologies updates its AI telehealth platform development for Latin America, focusing on remote care and analytics integration to improve healthcare access and efficiency.
April 16, 2026 — Aclarion secures U.S. patent for AI platform analyzing MRI data to identify painful spinal discs, expanding IP portfolio to 64 patents for chronic low back pain diagnosis technology.
April 15, 2026 — GeoVax Labs announces Phase 3 trial plans for GEO-MVA mpox/smallpox vaccine in 2026, addressing global supply constraints with accelerated regulatory pathway and manufacturing readiness.